Clinical Trials Browser

OTHER × Glioblastoma × cemiplimab × Clear all

NCT04826393 2025-10-22

ASP8374 + Cemiplimab in Recurrent Glioma

Phase 1 Completed

Glioblastoma, Glioma, Lymphoma, Follicular